Macrolide Resistance Determinants in Erythromycin-Resistant Streptococcus pneumoniae in Turkey

被引:0
|
作者
Gulay, Zeynep [1 ]
Ozbek, Ozgen Alpay [1 ]
Bicmen, Meral [1 ]
Gur, Deniz [2 ]
机构
[1] Dokuz Eylul Univ, Fac Med, Dept Microbiol & Clin Microbiol, TR-35340 Izmir, Turkey
[2] Hacettepe Univ, Childrens Hosp, Clin Microbiol Lab, Ankara, Turkey
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
To determine the major molecular mechanisms of macrolide resistance among Streptococcus pneumoniae isolates in Turkey, we examined a total of 151 isolates collected from different regions of Turkey. Overall, 40 (26.4%) isolates were resistant to erythromycin. The most common mechanism (38/40) was target site modification due to erm (B) genes. Only two isolates hat-bored the mef(A)/(E) efflux gene. A clonal spread of resistant strains could not be demonstrated by BOX-polymerase chain reaction. The results from this study have shown that the erm (B) gene is predominant in Turkish S. pneumoniae isolates, as in isolates from the rest of the world, and a clonal dissemination is not responsible for this resistance profile.
引用
收藏
页码:490 / 493
页数:4
相关论文
共 50 条
  • [41] Prevalence of Inducible Macrolide-Lincosamide-Streptogramin B (MLSB) Resistance in Erythromycin-Resistant Staphylococci
    Kim, Kyung-Hee
    Park, Soon-Ho
    Park, Pil-Whan
    Ahn, Jeong-Yeal
    Seo, Yiel-Hea
    INFECTION AND CHEMOTHERAPY, 2010, 42 (03): : 171 - 174
  • [42] ERYTHROMYCIN-RESISTANT
    SMULL, LL
    LANCET, 1961, 2 (719): : 266 - &
  • [43] Increased prevalence of erythromycin resistance in streptococci:: Substantial upsurge in erythromycin-resistant M phenotype in Streptococcus pyogenes (1979-1998) but not in Streptococcus pneumoniae (1985-1999) in Taiwan
    Hsueh, PR
    Teng, LJ
    Lee, LN
    Yang, PC
    Ho, SW
    Lue, HC
    Luh, KT
    MICROBIAL DRUG RESISTANCE, 2002, 8 (01) : 27 - 33
  • [44] Macrolide and ketolide resistance with Streptococcus pneumoniae
    Doern, Gary V.
    MEDICAL CLINICS OF NORTH AMERICA, 2006, 90 (06) : 1109 - +
  • [45] Macrolide prescriptions and erythromycin resistance of Streptococcus pyogenes
    Gagliotti, C
    Nobilio, L
    Milandri, M
    Moro, ML
    CLINICAL INFECTIOUS DISEASES, 2006, 42 (08) : 1153 - 1156
  • [46] Significance of macrolide resistance in Streptococcus pneumoniae
    Nuermberger, EL
    Bishai, WR
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (03) : 524 - 525
  • [47] Macrolide resistance in Belgian Streptococcus pneumoniae
    Lagrou, K
    Peetermans, WE
    Verhaegen, J
    Van Lierde, S
    Verbist, L
    Van Eldere, J
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (01) : 119 - 121
  • [48] Detection of macrolide resistance in Streptococcus pneumoniae
    Kimura, T
    Horii, T
    Morita, M
    Muramatsu, H
    Kanno, T
    Maekawa, M
    CHEMOTHERAPY, 2003, 49 (1-2) : 56 - 61
  • [49] Effect of macrolide usage on emergence of erythromycin-resistant Campylobacter isolates in chickensv
    Lin, Jun
    Yan, Meiguan
    Sahin, Orhan
    Pereira, Sonia
    Chang, Yun-Juan
    Zhang, Qijing
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (05) : 1678 - 1686
  • [50] Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae
    Mazzariol, Annarita
    Koncan, Raffaella
    Vitali, Luca Agostino
    Cornaglia, Giuseppe
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (06) : 1171 - 1176